Abbey M, Clifton P, Kestin M, Belling B & Nestel PEffect of fish oil on lipoproteins, lecithin:cholesterol acyltransferase, and lipid transfer protein activity in humans. Arteriosclerosis (1990) 10, 85–94.
Agren JJ, Hanninen O, Julkunen A, Fogelholm L, Vidgren H, Schwab U, Pynnonen O & Uusitupa MFish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels. Eur J Clin Nutr (1996) 50, 765–771.
Austin MA, Hokanson JE & Edwards KLHypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol (1998) 81, 7B–12B.
Bonaa KH, Bjerve KS, Straume B, Gram IT & Thelle DEffect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromso study. N Engl J Med (1990) 322, 795–801.
Buckley R, Shewring B, Turner R, Yaqoob P & Minihane AMCirculating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects. Br J Nutr (2004) 92, 477–483.
Conquer JA & Holub BJSupplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects. J Nutr (1996) 126, 3032–3039.
Conquer JA & Holub BJEffect of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background. J Lipid Res (1998) 39, 286–292.
Davidson MH, Maki KC, Kalkowski J, Schaefer EJ, Torri SA & Drennan KBEffects of docosahexaenoic acidon serum lipoproteins in patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled trial. J Am Coll Nutr (1997) 16, 236–243.
Fisher WR, Zech LA & Stacpoole PWApolipoprotein B metabolism in hypertriglyceridemic diabetic patients administered either a fish oil- or vegetable oil-enriched diet. J Lipid Res (1998) 39, 388–401.
Friedewald WT, Levy RI & Fredrickson DSEstimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 18, 499–502.
Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL & Buring JE (1997) Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation. 96 2520–2525
Geppert J, Kraft V, Demmelmair H & Koletzko B (2005) Docosahexaenoicacid supplementation in vegetarians effectively increases omega-3 index: a randomized trial. Lipids. 40 870–814.
Griffin BAThe effect of n-3 fatty acids on low density lipoprotein subfractions. Lipids (2001) 36 S91–S97
Grimsgaard S, Bonaa KH, Hansen JB & Myhre ES (1998) Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am J Clin Nutr.68 52 – 59
Grimsgaard S, Bonaa KH, Hansen JB & Nordoy A (1997) Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am J Clin Nutr. 66 649 – 659
Grover SA, Coupal L & Hu XP (1995) Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work?. JAMA. 274 801 – 806
Grover SA, Palmer CS & Coupal LSerum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohort. Arch Intern Med. (1994) 154 679 – 684
Harris WS (1997) N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 65.1645S – 1654S
Hess D, Keller HE, Oberlin B, Bonfanti R & Schuep W (1991) Simultaneous determination of retinol, tocopherols, carotenes and lycopene in plasma by means of high-performance liquid chromatography on reversed phase. Int J Vit Nutr Res. 61 232 – 238
Hodis HN (1999) Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis. Circulation. 99 2852 – 2854
Hokanson JE & Austin MA (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 3 213 – 219
Illingworth DR, Harris WS & Connor WE (1984) Inhibition of low density lipoprotein synthesis by dietary omega-3 fatty acids in humans. Arteriosclerosis 4 270 – 275
Inagaki M & Harris WSChanges in lipoprotein composition in hypertriglyceridemic patients taking cholesterol-free fish oil supplements. Atherosclerosis (1990) 82 237 – 246
Kinosian B, Glick H & Garland G (1994) Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med. 121 641 – 647
Kinosian B, Glick H, Preiss L & Puder KL (1995) Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios. J Invest Med. 43 443 – 450
Knapp HR & FitzGerald GA (1989) The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension. N Engl J Med. 320 1037 – 1043
Leigh-Firbank EC, Minihane AM, Leake DS, Wright JW, Murphy MC, Griffin BA & Williams CM (2002) Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses. Br J Nutr. 87 435 – 445
Lindsey S, Pronczuk A & Hayes KC (1992) Low density lipoprotein from humans supplemented with n-3 fatty acids depresses both LDL receptor activity and LDLr mRNA abundance in HepG2 cells. J Lipid Res. 33 647 – 658
Lu G, Windsor SL & Harris WS (1999) Omega-3 fatty acids alter lipoprotein subfraction distributions and the in vitro conversion of very low density lipoproteins to low density lipoproteins. J Nutr Biochem. 10 151 – 158
Lungershausen YK, Abbey M, Nestel PJ & Howe PRC (1994) Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives. J Hypertens. 12 1041 – 1045
Mori TA, Bao DQ, Burke V, Puddey IB & Beilin LJ (1999) Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 34 253 – 260
Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best tJD & Beilin LJ (2000) Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr. 71 1085 – 1094
Nelson GJ, Schmidt PC, Bartolini GL, Kelley DS & Kyle D (1997) The effect of dietary docosahexaenoic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids 32 1137 – 1146
Nestel PJ (2000) Fish oil and cardiovascular disease: lipids and arterial function.Am J Clin Nutr. 71 228 – 231
Nestel P, Shige H, Pomeroy M, Cehun M, Abbey M & Raederstorff D (2002) The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am J Clin Nutr. 76 326 – 330
Rambjor GS, Walen AI, Windsor SL & Harris WS (1996) Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans. Lipids. 31 S45 – S49
Sanders TAB & Hinds A (1992) The influence of a fish oil high in docosahexaenoic acid on plasma lipoprotein and vitamin E concentrations and haemostatic function in healthy male volunteers. Br J Nutr. 68 163 – 173
Schectman G, Boerboom LE, Hannah J, Howard BV, Mueller RA & Kissebah AH (1996) Dietary fish oil decreases low-density-lipoprotein clearance in nonhuman primates. Am J Clin Nutr. 64 215 – 221
Stark KD & Holub BJ (2004) Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy. Am J Clin Nutr. 79 765 – 773
Surette ME, Whelan J, Lu GP, Broughton KS & Kinsella JE (1992) Dependence on dietary cholesterol for n-3 polyunsaturated fatty acid-induced changes in plasma cholesterol in the Syrian hamster. J Lipid Res. 33 263 – 271
Theobald HE, Chowienczyk PJ, Whittall R, Humphries SE & Sanders TAB (2004) LDL cholesterol-raising effect of low-dose docosahexaenoic acid in middle-aged men and women. Am J Clin Nutr. 79 558 – 563
Toft I, Bonaa KH, Ingebretsen OC, Nordoy A & Jenssen T (1995) Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension: a randomized, controlled trial. Ann Intern Med. 123 911 – 918